Mork Capital Management, LLC Abb Vie Inc. Transaction History

Mork Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $233,604 - $289,837	-1,770 Reduced 19.03%	7,530 $1.22 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $1.32 Million - $1.45 Million	-12,900 Reduced 58.11%	9,300 $1.01 Million
Q4 2020 Feb 17, 2021	BUY	$80.49 - $108.67 $893,439 - $1.21 Million	11,100 Added 100.0%	22,200 $2.38 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $201,964 - $252,700	2,800 Added 33.73%	11,100 $983,000
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $646,155 - $796,883	8,300 New	8,300 $765,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Mork Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Mork Capital Management, LLC with notifications on news.